Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5499 USD | +4.74% | +13.38% | -91.66% |
Chart calendar TransCode Therapeutics, Inc.
Upcoming events on TransCode Therapeutics, Inc.
Past events on TransCode Therapeutics, Inc.
2024-04-03 09:10 | Q4 2023 Earnings Release |
2024-03-14 09:10 | RNA Leaders Europe Congress |
2024-01-08 09:00 | Extraordinary Shareholders Meeting |
2023-12-04 | San Antonio Breast Cancer Symposium |
2023-11-14 16:30 | Q3 2023 Earnings Release |
2023-10-19 13:30 | ThinkEquity Conference |
2023-09-11 | H.C. Wainwright Global Investment Conference |
2023-08-14 16:45 | Q2 2023 Earnings Release |
2023-05-09 | Annual General Meeting |
2023-04-13 | American Association for Cancer Research Meeting |
2023-03-31 16:01 | Q4 2022 Earnings Release |
2022-11-14 16:15 | Q3 2022 Earnings Release |
2022-11-09 14:30 | Sidoti Micro Cap Virtual Conference |
2022-10-26 14:30 | ThinkEquity Conference |
2022-10-03 13:00 | Chardan Genetic Medicines Conference |
2022-08-15 16:15 | Interim 2022 Earnings Release |
2022-06-22 11:00 | Annual General Meeting |
2022-06-13 17:30 | BIO International Convention |
2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-16 08:30 | Q1 2022 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,15 -6,07 -1.42% | -18,7 -18,7 0.18% | -19,4 -21,1 7.97% | -14,7 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 31/03/22 | 31/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -2,99 -2,90 -2.97% | -4,71 -3,90 -20.7% | -4,95 -5,30 6.54% | -5,53 -5,60 1.3% | -5,13 -5,10 -0.6% | -5,33 -5,60 4.87% | -4,06 -5,70 28.79% | -3,20 | -3,40 | -3,80 | -4,30 | |
Net income Million USD | Released Forecast Spread | -4,82 | |||||||||||
EPS USD | Released Forecast Spread | -264 | |||||||||||
Announcement Date | 31/03/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
Past sector events for TransCode Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- RNAZ Stock
- Calendar TransCode Therapeutics, Inc.